Rare Case of Intracardiac Renal Cell Carcinoma Metastasis with Response to Nivolumab: Case Report and Literature Review
Authors:
Open Access
- 20 December 2018
- journal article
- case report
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 11 (3) , 861-870
Abstract
Intracardiac metastases in the absence of inferior vena cava involvement is a rare occurrence in patients with metastatic renal cell carcinoma (mRCC). There is limited evidence regarding the efficacy and safety of standard treatment modalities for mRCC patients with intracardiac metastases. Presence of intracardiac metastases is known to indicate poor prognosis and may potentially increase risk of treatment-related complications. Recent advances in RCC management have integrated nivolumab, a programmed death-1 (PD-1) receptor inhibitor, as a preferred treatment option in the second-line setting after failure of prior anti-angiogenic therapy; or in combination with ipilimumab, an anti-Cytotoxic T-lymphocyte antigen-4 antibody as first-line therapy for intermediate to poor risk patients with mRCC. The efficacy and toxicity of nivolumab in patients with mRCC and intracardiac metastases has never been reported previously. We herein present the first reported case of mRCC with intracardiac metastasis and a resultant excellent response to nivolumab treatment and discuss the imaging techniques and treatment options for this rare presentation.Keywords
This publication has 29 references indexed in Scilit:
- Cardiac Metastasis in Renal Cell Carcinoma without Vena Cava or Atrial Involvement: an Unusual Presentation of Metastatic DiseaseRare Tumors, 2013
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based studyThe Lancet Oncology, 2013
- Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CTJournal of Nuclear Medicine, 2012
- Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumoursEuropean Heart Journal, 2011
- Sunitinib Malate, a Receptor Tyrosine Kinase Inhibitor, Is Effective in the Treatment of Restrictive Heart Failure due to Heart Metastases from Renal Cell CarcinomaCardiology, 2009
- Cardiac metastasis from renal cell carcinoma without inferior vena involvement: a review of the literature based on a case report. Two different patterns of spread?International Journal of Clinical Oncology, 2008
- Ventricular Metastasis without Atrial or Caval Involvement: A Rare PresentationEchocardiography, 2008
- Solitary Massive Right Ventricular Metastasis of Renal Cell Carcinoma Without Inferior Vena Cava or Right Atrium InvolvementJournal of Cardiac Surgery, 2006
- Renal-Cell CarcinomaNew England Journal of Medicine, 2005
- Metastatic Involvement of the Heart and Pericardium: CT and MR ImagingRadioGraphics, 2001